Work

Recognition of Azole-Resistant Aspergillosis by Physicians Specializing in Infectious Diseases, United States

Year: 2017

Type: article

Abstract: Infections caused by pan-azole-resistant Aspergillus fumigatus strains have emerged in Europe and recently in the United States.Physicians specializing in infectious diseases reported observing pan-azole-resistant infections and low rates of susceptibility testing, suggesting the need for wider-scale testing. I nfections with strains ofAspergillus fumigatus that are resistant to all azole antifungal medications have become common in western Europe and have been documented in other regions since 1998 (1,2), but until recently, had Recognition of Azole-Resistant Aspergillosis by Physicians Specializing in Infectious Diseases, United States Emerging Infectious Diseases • www.cdc.gov/eid• Vol. 24, No. 1, January 2018 111 In support of improving patient care, this activity has been planned and implemented by Medscape, LLC and Emerging Infectious Diseases.Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.Medscape, LLC designates this Journal-based CME activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™.Physicians should claim only the credit commensurate with the extent of their participation in the activity.All other clinicians completing this activity will be issued a certificate of participation.To participate in this journal CME activity: (1) review the learning objectives and author disclosures; (2) study the education content; (3) take the post-test with a 75% minimum passing score and complete the evaluation at http://www.medscape.org/journal/eid;and (4) view/print certificate.For CME questions, see page 190.

Source: Emerging infectious diseases

DOI: 10.3201/eid2401.170971